In conclusion, the first pan-cancer analysis of COPB2 indicated that COPB2 expression was significantly correlated with prognosis of cancer patients, genetic alteration, immune cell infiltration, and drug sensitivity in various tumors. Here, COPB2 is linked to cancer.